CHMP Nod Little Consolation As Amgen's Imlygic Becomes Melanoma Also-Ran

Europe's top scientific panel gives positive review to product (also known as T-VEC) for advanced melanoma but the treatment landscape has been transformed by innovative competitors over the past few years.